Elanco Animal Health Incorporated

NYSE:ELAN

10.44 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 1,0201,0301,1841,2051,0351,0681,0571,2579881,0281,1771,2251,1131,1311,2791,2421,139.7889.6586.3657.7787771.3781.6731.1799.3761.1770.2736.2754.3697.1718.8718.8
Cost of Revenue 631625626515516487434494448472484509512502551569596.2441.8295.9332.7410.1360.4356343.8412.5369.8431.5360405376.2343.1343.1
Gross Profit 389405558690519581623763540556693716601629728673543.5447.8290.4325376.9410.9425.6387.3386.8391.3338.7376.2349.3320.9375.7375.7
Gross Profit Ratio 0.3810.3930.4710.5730.5010.5440.5890.6070.5470.5410.5890.5840.540.5560.5690.5420.4770.5030.4950.4940.4790.5330.5450.530.4840.5140.440.5110.4630.460.5230.523
Reseach & Development Expenses 81878987798681818078828192949489112.788.159.466.867.369.968.864.161.158.961.465.26261.963.9563.95
General & Administrative Expenses 0000850001020008100018200182185.9192.3200.9181.1185.10000000
Selling & Marketing Expenses 000020700020100024800061100182000000000000
SG&A 300323354337292313353327303298343320329342385348374.1277.7162.8182185.9192.3200.9181.1185.1179191.1180196.8194.7194.2194.2
Other Expenses 00-2-9-34-9-231341301281331373-11314716.6114.947.9-1.1-6.3-14.6-3.9-2.6-25.7-13.5-8.8-1.901.900
Operating Expenses 381410443557509539570542513504558538560577608584650.5461.4271.2300.4304.6312.9319294.2296.3286.6301.9294.4319308.2409.7409.7
Operating Income 8-5115133-244253212644135169-665212089-107-13.619.224.672.398106.693.190.5104.736.881.830.312.762.8562.85
Operating Income Ratio 0.008-0.0050.0970.11-0.0230.0390.050.1690.0060.0430.1150.138-0.0590.0460.0940.072-0.094-0.0150.0330.0370.0920.1270.1360.1270.1130.1380.0480.1110.040.0180.0870.087
Total Other Income Expenses Net -59564-147-121-137-1,139-132-113-185-94-153-107-55-182-356-169-211.1-195.4-96.3-92.4-76.6-110.5-56.4-48.3-92.7-25.9-76.8-4.3-185.7-21.8-96.85-96.85
Income Before Tax -51559-3212-127-1,097-79108-88-42-1871-121-130-236-80-318.1-209-77.1-67.8-4.3-12.550.244.8-2.278.8-4077.5-155.4-9.1-34-34
Income Before Tax Ratio -0.050.543-0.0270.01-0.123-1.027-0.0750.086-0.089-0.041-0.0150.058-0.109-0.115-0.185-0.064-0.279-0.235-0.132-0.103-0.005-0.0160.0640.061-0.0030.104-0.0520.105-0.206-0.013-0.047-0.047
Income Tax Expense -4319518-2014-1185-347423-24-26-26-194.7-74-23.9-18.75.2-22.514.313.3-18.618.622.84.86.111.630.2530.25
Net Income -8364-5032-141-1,096-97103-54-49-2251-97-104-210-61-322.8-135-53.2-49.1-9.51035.931.516.460.2-62.872.7-161.5-20.7-64.25-64.25
Net Income Ratio -0.0080.353-0.0420.027-0.136-1.026-0.0920.082-0.055-0.048-0.0190.042-0.087-0.092-0.164-0.049-0.283-0.152-0.091-0.075-0.0120.0130.0460.0430.0210.079-0.0820.099-0.214-0.03-0.089-0.089
EPS -0.0160.74-0.10.06-0.29-2.22-0.20.21-0.11-0.1-0.0450.1-0.2-0.21-0.43-0.13-0.66-0.29-0.13-0.12-0.0260.030.10.090.040.16-0.180.2-0.45-0.05700
EPS Diluted -0.0160.73-0.10.06-0.29-2.22-0.20.21-0.11-0.1-0.0450.1-0.2-0.21-0.43-0.13-0.66-0.29-0.13-0.12-0.0250.030.10.090.040.16-0.180.2-0.44-0.05700
EBITDA 8-5195299111-852230394146217304352114100293293-34.7-28.619.224.697.8176.7148.1140.892.5177.435.3156.1117.487.9140.9140.9
EBITDA Ratio 0.008-0.0050.2340.2410.1420.1620.1570.2750.1380.2050.2280.2820.1640.1610.2290.2340.0640.2630.2520.160.1490.1740.1940.1910.2330.2180.1340.2090.4020.160.1960.196